Phase I Dose-Escalation Study of Docetaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients With Advanced Esophageal Carcinoma

A dose-escalation study of docetaxel (DOC), cisplatin (CDDP), and 5-fluorouracil (5-FU; DCF combination regimen) was performed to determine the maximum-tolerated dose (MTD), recommended dose (RD) and dose-limiting toxicities (DLT) in advanced esophageal carcinoma. Eighteen patients with esophageal c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Surg
Main Authors: Satomura, Hitoshi, Nakajima, Masanobu, Sasaki, Kinro, Yamaguchi, Satoru, Domeki, Yasushi, Takahashi, Masakazu, Muroi, Hiroto, Kubo, Tsukasa, Kikuchi, Maiko, Otomo, Haruka, Ihara, Keisuke, Kato, Hiroyuki
Formato: Artigo
Idioma:Inglês
Publicado em: The International College of Surgeons, World Federation of General Surgeons and Surgical Specialists, Inc. 2015
Assuntos:
Upper Gastrointestinal
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4587522/
https://ncbi.nlm.nih.gov/pubmed/26414837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9738/INTSURG-D-14-00233.1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados